Del.icio.us
Google
Yahoo MyWeb
Facebook
Neosil Overview
Neosil is a privately-held dermatology-focused specialty pharmaceutical company with several products in pre-clinical development. The company’s core topical anti-infective technology provides broad anti-microbial activity, long duration of activity and excellent formulation flexibility. The technology is based upon the work of polymer chemist, Dr. Samuel P. Sawan, a Professor in the Department of...More»
Neosil is a privately-held dermatology-focused specialty pharmaceutical company with several products in pre-clinical development. The company’s core topical anti-infective technology provides broad anti-microbial activity, long duration of activity and excellent formulation flexibility. The technology is based upon the work of polymer chemist, Dr. Samuel P. Sawan, a Professor in the Department of Chemistry at the University of Massachusetts, Lowell.
Neosil was acquired by Peplin in June 2008.«Less
Funding
| Date | Type | Capital Amount | Post-Money Valuation | Investors |
|---|---|---|---|---|
| 11/04/2004 | Series A | 32M | Unknown |
Products
No product information added yet. Add product information.
Competitors
No competitors have been recorded yet. Add a competitor.
Related Companies
No related companies were found.
User Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »
Web Metrics
View All Web Metrics »
| Alexa Rank: | n/a |  |
n/a |
| Yahoo Search Results: | n/a | ||
Neosil on Twitter
Twitter Search »Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.
Related Jobs
loading...